Category Archives: ccrh

India to tie up top institutes for advanced research in Homoeopathy

research

New Delhi: Buoyed by the success of the World Summit in Mumbai, the Central Council for Research in Homeopathy (CCRH) plans to have a tie-up with other research organisations with the aim of taking the health-care industry to the next level.

With recent researches having yielded information on genomics which can be juxtaposed on the effect of homeopathic medicines individualised at molecular level, CCRH director general R.K. Manchanda has called for further research in the area.

He pointed out that CCRH — an autonomous body under the government of India’s Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy (AYUSH) — has been instrumental in cutting-edge research publications on cancer, Japanese encephalitis, diabetes, urolithiasis, memory function and detection of nano-particles in high homeopathic dilutions.

The council has already found integration of homeopathic and allopathic medicines to be successful in tackling MDR-TB.

Manchanda expressed happiness the huge participation in the World Homeopathy Summit on April 11-12, which CCRH held the summit in association with the Global Homeopathy Foundation, proved that homeopathy is not a placebo medicine and that it is science.

The summit was attended by scientists from Brazil and Italy as well as those from the Indian Council of Medical Research (ICMR), IIT-Bombay, Institute of Chemical Technology (ICT) Mumbai, Indian Institute of Chemical Technology (IICT) Hyderabad, Haffkine Institute Mumbai, Council of Scientific and Industrial Research (CSIR) and Bose institute – Kolkata.

“The deliberations at the summit held recently and the ocean of information on the research done into treatment of AIDS, cancer, influenza and TB and the detection of nano-particles in homeopathic medicines will definitely take homeopathy to an altogether new dimension,” he said.

Questions have been raised about homeopathy — whether it is a science at all and if it works and how does it work. “Now, we are in a position to declare to the world that researches have conclusively proved that homeopathy works, and works effectively in several cases of complicated diseases,” declared Dr Rajesh Shah, organising secretary of the summit.

Molecular biologist Dr Gaurisankar from Bose institute – Kolkata, demonstrated that cancer tumour regressed significantly after administering homeopathic nano-particles of Calcaria Carbonicum. His research has proved that high-dilution homeopathic nano-particles could kill the cancer cells and considerably reduce the cancer tumours in rats.

Snake venom transformed into a homeopathic medicine could reduce the growth of HIV virus by inhibiting RT (reverse transcriptase), an enzyme required for the multiplication of the deadly HIV, Hepatitis C and Ebola virus, studies at Indian Institute of Chemical Technology (IICT), Hyderabad, showed. IICT scientists Dr Praveen Kumar and Dr Prathama feel this research opens a new way to treat HIV and other such diseases, including Ebola.

In a study by Dr Khuda Bukshsh, genotoxic effects of arsenic trioxide poisoning were successfully treated using potentised arsenic metal, proving the very fundamental principle of homeopathy, which says that like can be cured by likes, if administered in extremely small dose.

Similarly, he demonstrated that mercury, cadmium and tin toxicity also reduced with the corresponding homeopathic medicines prepared from the same metals. “Treatment of toxicity is another area which could be addressed by homeopathy,” said GHF chairman Eswara Das, also an ex-advisor of AYUSH.

Cancer surgeon Dr Arun Jamkar, vice-chancellor of Maharashtra University of Health Sciences (MUHS), said in his keynote address that recent research has created adequate evidence for the efficacy of homeopathic medicines. He opined that homeopathy and conventional medicine could be integrated to benefit the patients.

A major research done in Brazil by Dr Leoni Bonamin and team demonstrated the preventive affects of homeopathic medicine prepared from the influenza virus. “This research opens up windows to many more research opportunities in India,” said Dr. Shah, who is also working on developing more medicines sourced from various germs.

Source : http://www.homeobook.com/india-to-tie-up-top-institutes-for-advanced-research-in-homoeopathy/

Advertisements

Immunological studies on Rheumatoid Arthritis treated with Homeopathic drugs: Results of the Pilot Study

Research Paper from CCRH

Immunological studies on Rheumatoid Arthritis treated with Homeopathic drugs: Results of the Pilot Study by  Prakash Rao  & Nagalakshmi Prasanna M
Clinical Research Unit (Homoeopathy) Puducherry
Senior Research Fellow, JIPMER, Puducherry

Introduction & Objective: Rheumatoid Arthritis (RA), a systemic disease, is characterized by a chronic inflammatory reaction in the synovium of joints. The inflammation is mediated by inflammatory cytokines. The objective of the study was to evaluate efficacy of homeopathic drugs and changes in the cytokine profile of rheumatoid arthritis patients treated with homeopathic drugs. Materials and Methods: A total of 35 rheumatoid arthritis patients and 10 healthy controls completed this pilot study. The patients were treated with Rhus tox. (8), Pulsatilla (8) and Medorrhinum (9) according to totality of symptoms. The control group (10) received placebo. The patients were evaluated for disease activity at the time of enrollment in the study and after 3 weeks of therapy. Serum cytokine levels (IL-1α, IL-1β, IL-2, IL-6 and TNF-α) were measured at baseline and after 3 weeks of treatment.
Result: Patients receiving Rhus tox. showed significant improvement in Patient Visual Analogue Score (VAS) for global assessment of disease after 3 weeks of therapy compared to placebo group(p = 0.03). Patients receiving Pulsatilla showed a significant improvement in tender joint count (p = 0.01) at the end of 3 weeks compared to baseline. They also showed significant decrease in ESR (p
= 0.02) as compared to placebo. However, hs-CRP values in treatment groups did not show significant difference when compared to the placebo group at baseline and after therapy. There was a significant decrease in IL 6 levels after 3 weeks of therapy in the patients treated with Rhus tox. and Medorrhinum
compared to placebo (p=0.05 and 0.04 respectively). Surprisingly, there was a significant increase in IL 6 level in the placebo group compared to their baseline values (p = 0.04), suggesting ineffectiveness of placebo and worsening of the disease process.
Conclusion: In the present open label placebo controlled pilot study patients treated with 3 weeks of homeopathic drugs showed improvement in clinical features, reduction in parameters of inflammation and IL6 levels. These observations suggest a possible immunomodulatory role of homeopathic drugs in Rheumatoid Arthritis which need to be confirmed by further studies.

Detailed Report with download link : http://homeopathyresearches.blogspot.in/2013/05/immunological-studies-on-rheumatoid.html